Sleep Disorders Trial, Recruiting (NCT07385105)

Sleep Disorders Trial, Recruiting NCT07385105 Sponsor: University of Missouri-Columbia Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07385105 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed by a doctor with a mild traumatic brain injury (such as a concussion) and have had sleep problems for more than 4 weeks
You scored 10 or higher on a standard sleep questionnaire called the Insomnia Severity Index, which measures how serious your sleep difficulties are
You are able to speak, read, and write in English

Who may not be able to join:

You have a history of other brain or nervous system conditions, or other psychological (mental health) conditions
You scored higher than 20 on a depression questionnaire called the PHQ-9, which would indicate severe depression symptoms
You scored higher than 15 on an anxiety questionnaire called the GAD-7, which would indicate severe anxiety symptoms
You scored below 24 on a memory and thinking assessment called the MoCA, which may suggest difficulties with thinking or memory (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 573-823-3082

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07385105

Sponsor: University of Missouri-Columbia

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 573-823-3082

More information: https://clinicaltrials.gov/study/NCT07385105

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed by a doctor with a mild traumatic brain injury (such as a concussion) and have had sleep problems for more than 4 weeks
You scored 10 or higher on a standard sleep questionnaire called the Insomnia Severity Index, which measures how serious your sleep difficulties are
You are able to speak, read, and write in English

Who may not be able to join:

You have a history of other brain or nervous system conditions, or other psychological (mental health) conditions
You scored higher than 20 on a depression questionnaire called the PHQ-9, which would indicate severe depression symptoms
You scored higher than 15 on an anxiety questionnaire called the GAD-7, which would indicate severe anxiety symptoms
You scored below 24 on a memory and thinking assessment called the MoCA, which may suggest difficulties with thinking or memory (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Missouri-Columbia

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The expanded consensus sleep diary (CSD); Insomnia Severity Index (ISI); Pittsburgh Sleep Quality Index (PSQI); Epworth Sleepiness Scale (ESS); Canadian Occupation Performance Measure (COPM); Activity Card Sort (ACS); Feasibility of Intervention Measure (FIM); Client Satisfaction Questionnaire (CSQ-8); Insomnia Severity Index (ISI); Pittsburgh Sleep Quality Index (PSQI); Epworth Sleepiness Scale (ESS); Canadian Occupation Performance Measure (COPM); Activity Card Sort (ACS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov